News

Moiz Master, M.D. Takes Helm as Chief Medical Officer at Piedmont

Moiz Master, M.D. Takes Helm as Chief Medical Officer at Piedmont

Moiz Master, M.D. Named Chief Medical Officer of Piedmont Healthcare

Piedmont Healthcare recently announced the appointment of Dr. Moiz Master as its new Chief Medical Officer (CMO). This significant transition follows the retirement of Dr. Leigh Hamby, who has dedicated over twenty years of service to enhancing healthcare excellence at Piedmont. Dr. Master, who has been an integral part of the healthcare team since 2021 as the assistant CMO, has a wealth of experience that will be instrumental in the growth and development of Piedmont's healthcare operations.

Dr. Moiz Master's Accomplishments

Under Dr. Master’s leadership at Piedmont Mountainside Hospital, he achieved a remarkable record of nineteen consecutive A grades from the Leapfrog Group. This achievement not only reflects the high standards of patient safety but also underscores his commitment to quality healthcare. His strategic initiatives led to a 50% reduction in excess stay days, thereby increasing hospital capacity equivalent to accommodating an additional 150 beds. This accomplishment is a testament to his innovative approach in streamlining healthcare processes to better serve the community.

Leadership and Vision

Piedmont Healthcare President and CEO, Kevin Brown, expressed confidence in Dr. Master’s capabilities, stating, "Dr. Master brings a wealth of clinical and healthcare leadership experience to the role." His extensive background, which includes over 25 years as a practicing internist and healthcare leader, positions him to continue fostering Piedmont's reputation for clinical excellence through innovative collaborations and quality improvements.

Dr. Master’s Educational Journey

Dr. Master earned his medical degree from Topiwala National Medical College in Mumbai, India. His medical training saw him initially focusing on orthopedics and general surgery before making his way to the United States. There, he completed his residency in Internal Medicine at the University of Connecticut, where he also served as Chief Resident, distinguishing himself as a leader among his peers.

Continuity in Leadership at Piedmont

As Dr. Hamby transitions into retirement, he will not be far from the healthcare environment. He will continue to contribute to the Piedmont Clinic part-time as a senior performance improvement lead. His legacy of driving Piedmont’s transformation and response to challenges, particularly during the COVID-19 pandemic, has set a high standard for future leadership.

Acknowledgments from Leadership

Kevin Brown took a moment to acknowledge Dr. Hamby’s significant impact, especially in shaping Piedmont's response to the pandemic. His leadership in establishing the COVID command center was crucial in coordinating efforts to meet the healthcare demands posed by the virus, ensuring that patient safety remained a top priority.

Looking Ahead: A Focus on Excellence

With Dr. Master at the helm as CMO, Piedmont Healthcare is poised for continued excellence in patient care. His focus on quality improvement and patient-centric healthcare will drive the organization forward in its mission to provide the best services possible to the community. Dr. Master’s commitment to clinical excellence, coupled with his innovative leadership style, will play a pivotal role in shaping the future of healthcare delivery at Piedmont.

Frequently Asked Questions

Who is the new Chief Medical Officer at Piedmont Healthcare?

The new Chief Medical Officer is Dr. Moiz Master, who previously served as the assistant CMO.

What achievements did Dr. Moiz Master have at Piedmont Mountainside?

Dr. Master achieved nineteen consecutive A grades from the Leapfrog Group and led a significant reduction in hospital stay days.

What is Dr. Hamby's future role after retirement?

Dr. Leigh Hamby will continue to serve part-time as a senior performance improvement lead at the Piedmont Clinic.

What educational background does Dr. Master have?

Dr. Master earned his medical degree from Topiwala National Medical College in Mumbai and completed his residency in Internal Medicine at the University of Connecticut.

How long has Dr. Hamby served at Piedmont?

Dr. Leigh Hamby served at Piedmont for over twenty years before retiring.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

China Automotive Systems Hits Milestone with ASPICE 4.0 CL2

Updated Category News Views 16

An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....

Continue Reading
OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Updated Category News Views 16

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Continue Reading
#L.A. Rising Podcast: From Fires to International Fame

Updated Category News Views 18

From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...

Continue Reading
Christmas Injury Lawyers Unveils SC Knowledge Center

Updated Category News Views 6

In the world of legal labyrinths, sometimes you just need a guiding light, especially following a car accident. That's where the freshly launched South Carolina Car Accident Law Knowledge Center steps in. It’s no magic wand, but Christmas Injury Lawyers are certainly trying to cut the chaos. This online hub covers more ground than a small library, boasting 40 guides...

Continue Reading
Travelers Turn to Direct Booking Amid Cost Surge

Updated Category News Views 20

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

Continue Reading
Dan Brown Joins Guidewire: Big Moves in P&C Software

Updated Category News Views 17

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

Continue Reading
Event Industry Power 50 Voting Surge Ahead of Close

Updated Category News Views 15

An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....

Continue Reading
ProClad Unveils Innovative Hybrid 2.0 Cookware

Updated Category News Views 15

Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...

Continue Reading
TRIMAX Poised to Meet AI-Driven Power Challenges

Updated Category News Views 13

TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...

Continue Reading
Palm Beach Royals Boost Pickleball's Popularity Surge

Updated Category News Views 23

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

Continue Reading

Top 5 Most Recently Viewed Articles

First Western Financial Soars to 52-Week High at $21.19!

Updated Category News Views 39

First Western Financial Achieves New Milestone In an impressive display of market performance, First Western Financial, Inc. (NASDAQ: MYFW) has achieved a remarkable 52-week high, trading at an encouraging $21.19. This peak illustrates a significant upward trend for the regional bank holding company, which recorded a stellar 1-year growth of 18.83%. Investors are keenly...

Continue Reading
TransMedics Group Announces Inducement Stock Option Grants

Updated Category News Views 64

TransMedics Group Announces Inducement Stock Option Grants TransMedics Group, Inc. (NASDAQ: TMDX) is at the forefront of revolutionizing organ transplant therapies for patients with severe pulmonary, cardiac, and hepatic diseases. Recently, the company revealed an exciting development regarding stock options for its employees as part of its competitive benefits. Recent...

Continue Reading
ADC Therapeutics Plans Q1 2025 Financial Call for Investors

Updated Category News Views 141

ADC Therapeutics to Share First Quarter 2025 Results ADC Therapeutics SA (NYSE: ADCT), a prominent leader in antibody drug conjugates (ADCs), has announced an exciting event for investors. The company will host a conference call and live webcast to discuss its financial performance for the first quarter of 2025. This informative session is set to take place on May 14,...

Continue Reading
BlueHalo Secures $49.9M Contract to Enhance UAS Warfare Systems

Updated Category News Views 196

BlueHalo Receives Major Contract for Electronic Warfare Systems BlueHalo, renowned for transforming global defense with its cutting-edge Electronic Warfare (EW) capabilities, has earned a contract worth $49.9 million from the Naval Information Warfare Center (NIWC) Pacific. This five-year agreement signifies a substantial commitment to delivering hardware, materials, and...

Continue Reading
Revelation Biosciences Navigates Nasdaq Compliance Challenges

Updated Category News Views 68

Overview of Revelation Biosciences' Current Situation Revelation Biosciences, Inc. is currently facing a significant challenge that could lead to its delisting from The Nasdaq Stock Market LLC. The company, known for its innovative pharmaceutical developments, received notifications indicating that it was not able to meet Nasdaq's minimum bid price and shareholder equity...

Continue Reading